Cargando…
Inflammatory Myofibroblastic Tumour: State of the Art
SIMPLE SUMMARY: Among sarcomas, which are rare cancers, inflammatory myofibroblastic tumors are extremely rare. Unlike other subtypes, this is a largely oncogene-driven neoplasia, and early gene rearrangement identification is important for accurate advanced stage treatment. In this manuscript, we r...
Autores principales: | Gros, Louis, Dei Tos, Angelo Paolo, Jones, Robin L., Digklia, Antonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367282/ https://www.ncbi.nlm.nih.gov/pubmed/35954326 http://dx.doi.org/10.3390/cancers14153662 |
Ejemplares similares
-
Immunotherapy for Esophageal Cancer: State-of-the Art in 2021
por: Teixeira Farinha, Hugo, et al.
Publicado: (2022) -
Mesenchymal tumours of the gastrointestinal tract
por: Sbaraglia, Marta, et al.
Publicado: (2021) -
Inflammatory myofibroblastic tumour of the gallbladder
por: Behranwala, Kasim A, et al.
Publicado: (2005) -
Inflammatory myofibroblastic tumours: a pictorial review
por: Cantera, Jon Etxano, et al.
Publicado: (2014) -
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives
por: Sbaraglia, Marta, et al.
Publicado: (2020)